Luis A. Dasta
FDA investigator
Appears on 2 documents from 2015, mostly at sites in India. Most often cites testing and release for distribution (21 CFR 211.165).
- 2
- Documents on file
- 1.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 2 observations- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2015: 2
Where
India 1 · Pennsylvania 1
Often inspects with
Is Luis A. Dasta coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-07-17 | 483 Lupin LimitedJul 17, 2015 · Verna, India | Verna, India | 1 | |
| 2015-05-26 | 483 Air Liquide Healthcare America CorporationMay 26, 2015 · Plumsteadville, Pennsylvania | Plumsteadville, Pennsylvania | 1 |
About this profile
What does Luis A. Dasta inspect?
Luis A. Dasta appears on 2 documents on file covering 2 sites, mostly in India.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.192 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Luis A. Dasta is dated Jul 17, 2015.